Claude Sada, Chief Operating Officer at Survitec, emphasised the importance of the attestation in accelerating regulatory engagement and industry adoption, “The endorsement by BV validates years of ...

Kazuya Shiraishi's 11 Rebels may occasionally feel long-in-the-tooth, but thanks to some great characters and excellent ...

Electric Vehicle (EV) major Tesla is not interested in manufacturing in India but is looking at opening two stores, Union Heavy Industries Minister H D Kumaraswamy said on Monday. He, however, said ...

Adding to the excitement, the film’s wedding song, Sada Ashna, has just been released and is already making waves on social media. Featuring a colourful Pashto melody, Sada Ashna brings an ...

was operating behind the Sada sub-jail premises at Headland-Sada, police said.A complaint was consequently lodged by police sub-inspector, Stanley Gomes, on behalf of the state. All the members of ...

Y-mAbs announces positive Phase 1 Trial 1001 results for GD2-SADA in cancer, plans further studies with optimized radiohapten "Proteus." Y-mAbs Therapeutics, Inc. announced positive results from ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings. kAmkDEC@?8m|2J `g\|2J ack^DEC@?8mk^Am kAmR q=@F?E r@F?EJ ...

We've just discovered that a collector's edition of Dragon Quest 1 & 2 HD-2D Remake is also on the way. Square Enix says quantities are "limited," so if you're keen, better hop on over to the ...

Update [Tue 27th May 2025, 9:15am]: As highlighted by Wario64 on Bluesky, it's confirmed that Dragon Quest I & II HD-2D Remake will be a Game-Key Card release for the Switch 2. This means that the ...

Dragon Quest 1 + 2 HD-2D Remake now has a confirmed release date, and a trilogy edition has also been announced. The game will be available on 30th October this year across Switch, Switch 2 ...

Rather than a full, polygonal upgrade, Square Enix is utilizing the retro-modern fusion they call HD-2D from its Octopath series to revive games like Dragon Quest 3 for modern audiences.

Y-mAbs announces GD2-SADA clinical trial presentation for treating GD2-expressing tumors at the Advances in Neuroblastoma Research Meeting. Y-mAbs Therapeutics, Inc. has announced the presentation ...